Starbucks Stock: Revenue Growth Clashes With Margin Pressure, Dividing Analysts

Starbucks (NASDAQ: SBUX) shares are at the center of a debate between investors weighing the progress of its turnaround strategy against a valuation that appears to price in a full recovery. While the company has demonstrated consistent top-line growth, its profitability has come under significant pressure, leading to a wide dispersion of views on Wall Street.

Revenue Growth Masks Margin Erosion

On the surface, Starbucks' revenue figures paint a positive picture, climbing approximately 28% cumulatively from $29.06 billion in fiscal year 2021 to $37.18 billion in fiscal 2025, according to an Investing.com report. However, a closer look at profitability reveals a more challenging environment.

Key metrics highlight the margin compression the company has faced due to cost inflation, labor investments, and restructuring charges:

• Net income fell from $4.12 billion in fiscal 2023 to $1.86 billion in fiscal 2025.
• The gross margin compressed from 29.0% to 23.0% over the same period.
• Consequently, the net income margin declined sharply from 14.5% to just 5.0%.

A Premium Valuation Under Scrutiny

Ad

The divergence between sales growth and profitability has put the stock's valuation under the microscope. Trading at 37.9 times forward earnings, Starbucks commands a roughly 72% premium to the broader market. Jefferies noted the stock trades at approximately 35 times forward earnings, compared to an average of 21 times for its global franchised peers.

This demanding valuation suggests the market is anticipating a near-flawless execution of its recovery plan. An analysis by InvestingPro's Fair Value model pegs the stock's intrinsic value at $87.62, implying a potential downside of 9.6% from its September 15 price of $96.96.

Wall Street Divided on Recovery Pace

Analysts are broadly constructive on the turnaround narrative but disagree on the timing and magnitude of the margin recovery. The consensus price target suggests a 13.1% upside, but individual targets range from a low of $95 (Guggenheim) to a high of $137 (Bank of America), reflecting deep uncertainty.

Bulls point to positive momentum, including a 7.1% rise in U.S. same-store sales for the second quarter of fiscal 2026, as noted by Piper Sandler. However, skeptics like Guggenheim argue the current valuation already reflects too much future success. Analysts at UBS highlighted North American operating margins as the critical metric for investors to watch in the coming quarters.